MDG_LOGO_2016_GRAY_RGB.jpg
Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
15. Mai 2024 09:00 ET | Medigene AG
Planegg/Martinsried, May 15, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...
MDG_LOGO_2016_GRAY_RGB.jpg
Medigene to Present at Upcoming Conferences
07. Mai 2024 09:00 ET | Medigene AG
Planegg/Martinsried, May 7, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...